Free Trial
OTCMKTS:GBCS

Selectis Health (GBCS) Stock Price, News & Analysis

Selectis Health logo
$2.25 0.00 (0.00%)
As of 07/3/2025

About Selectis Health Stock (OTCMKTS:GBCS)

Key Stats

Today's Range
$2.25
$2.25
50-Day Range
$1.51
$2.25
52-Week Range
$0.41
$4.50
Volume
N/A
Average Volume
437 shs
Market Capitalization
$6.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GBCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Selectis Health and its competitors with MarketBeat's FREE daily newsletter.

GBCS Stock News Headlines

Selectis Health Delays Q1 2025 10-Q Filing
Selectis Health Delays Yearly Report Filing
Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
Selectis Health Makes Key Leadership Announcement
Best Electric Wheelchairs Of 2024
See More Headlines

GBCS Stock Analysis - Frequently Asked Questions

Selectis Health's stock was trading at $1.12 at the start of the year. Since then, GBCS shares have increased by 100.9% and is now trading at $2.25.

Selectis Health, Inc. (OTCMKTS:GBCS) issued its quarterly earnings results on Tuesday, May, 20th. The company reported ($0.22) earnings per share (EPS) for the quarter. The firm earned $10.49 million during the quarter.

Selectis Health's stock reverse split on Wednesday, September 22nd 2021.The 1-10 reverse split was announced on Wednesday, September 22nd 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 22nd 2021. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of GBCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Selectis Health investors own include Chemed (CHE), Walt Disney (DIS), OceanFirst Financial (OCFC), Celanese (CE), Credit Acceptance (CACC), Blackstone Mortgage Trust (BXMT) and Blackstone (BX).

Company Calendar

Last Earnings
5/20/2025
Today
7/07/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Services
Sub-Industry
Trading
Current Symbol
OTCMKTS:GBCS
Employees
500
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.42 million
Pretax Margin
-5.05%

Debt

Sales & Book Value

Annual Sales
$39.49 million
Price / Cash Flow
N/A
Book Value
($2.02) per share
Price / Book
-1.11

Miscellaneous

Free Float
2,601,000
Market Cap
$6.91 million
Optionable
Not Optionable
Beta
-0.40
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:GBCS) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners